Correlation Between Avadel Pharmaceuticals and Pharmala Biotech

Can any of the company-specific risk be diversified away by investing in both Avadel Pharmaceuticals and Pharmala Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avadel Pharmaceuticals and Pharmala Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Avadel Pharmaceuticals PLC and Pharmala Biotech Holdings, you can compare the effects of market volatilities on Avadel Pharmaceuticals and Pharmala Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avadel Pharmaceuticals with a short position of Pharmala Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avadel Pharmaceuticals and Pharmala Biotech.

Diversification Opportunities for Avadel Pharmaceuticals and Pharmala Biotech

0.0

Correlation Coefficient

Avadel Pharmaceuticals  Pharmala Biotech

Pay attention - limited upside

The 3 months correlation between Avadel and Pharmala is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Avadel Pharmaceuticals PLC and Pharmala Biotech Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmala Biotech Holdings and Avadel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avadel Pharmaceuticals PLC are associated (or correlated) with Pharmala Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmala Biotech Holdings has no effect on the direction of Avadel Pharmaceuticals i.e., Avadel Pharmaceuticals and Pharmala Biotech go up and down completely randomly.

Pair Corralation between Avadel Pharmaceuticals and Pharmala Biotech

If you would invest (100.00) in Pharmala Biotech Holdings on December 4, 2024 and sell it today you would earn a total of  100.00  from holding Pharmala Biotech Holdings or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Avadel Pharmaceuticals PLC  vs.  Pharmala Biotech Holdings

Avadel Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Avadel Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pharmala Biotech Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharmala Biotech Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Pharmala Biotech is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Avadel Pharmaceuticals and Pharmala Biotech

The main advantage of trading using opposite Avadel Pharmaceuticals and Pharmala Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avadel Pharmaceuticals position performs unexpectedly, Pharmala Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmala Biotech will offset losses from the drop in Pharmala Biotech's long position.

The idea behind Avadel Pharmaceuticals PLC and Pharmala Biotech Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.